Basics: short version, verdict first People Molecules Peptides Biomarkers Studies Stem Cells Editorial Methodology
Layer 1 · Decision
← All products

Mitopure® Softgel

Mitochondrial · Softgel · 30 servings

Label snapshot

What the label says

What the product contains and what one serving costs, according to our catalog. Label amounts are not personal dose recommendations.

Active per serving
Urolithin A 500 mg
Form
Softgel
List price (catalog, USD)
$65.00
Price per serving
$2.17List price divided by servings per container. A per-day cost only if the label serving is once daily.
Full label record: servings, testing, ingredients
Servings per container
30
Serving size (label)
1 g
Catalog monthly estimate
$65.00
Testing disclosure
Brand lists third-party testing; no public lab certificate listedStatus as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Ingredients as listed

IngredientAmount per serving
Urolithin A500 mg

What to check on the label

  • Which form of the compound the label names (for CoQ10: ubiquinol or ubiquinone) and whether the milligrams refer to that form.
  • Softgel oil carriers are listed under 'other ingredients'. They are not part of the active amount.
  • Branded ingredients (Mitopure, BioPQQ and similar) should be named on the label if the brand claims them.

Amounts are per label serving as recorded in the catalog and are not a recommendation. Testing status reflects what the brand lists. Nothing here is medical advice.

Editorial score and research-dose calculations

These calculations describe our scoring method. They are not a recommended dose or proof of benefit from this product.

8.6/10
Overall score
#2 / 30 in Mitochondrial

Full trial dose, tested by independent lab.

Read the evidence (2 studies)
Watch out
Tier 1
Product RCT (peer-reviewed)
Strongest evidence: a peer-reviewed RCT tested this exact product.
See the 2 supporting studies
How we scored this product Show the full breakdown
Composite How this 8.6 is built. 0.50 × 10.0 + 0.20 × 8.0 + 0.10 × 4.0 + 0.10 × 8.0 + 0.05 × 7.0 + 0.05 × 8.6 = 8.6 out of 10. Safety caps applied after. 8.6
8.6 composite
Dose vs. studies50%10.0
Transparency20%8.0
Value10%4.0
Formulation10%8.0
Safety5%7.0
Community5%8.6

Evidence gates dose: the evidence grade sets the ceiling, and the dose decides how much of that ceiling the product reaches. Value = inverse of price-per-trial-dose-day. Community = mean sentiment of external reviews. Safety caps applied after weighting.

This score is our editorial judgment, not a scientific standard. We combine published evidence, dose, price, transparency, and consumer signals into one composite: this is our method, not a peer-reviewed clinical rating. A higher score means a product does better on the factors we weight, not that it is medically proven to work.

Read the full method →

Editorial verdict

Quick verdict

8.6 / 10
Best for
Full trial dose
Avoid if
No public lab certificate
Full-dose status
Meets trial dose
Price/month
$65
COA status
Not public
Biggest caveat
No public lab certificate available for independent verification.
Nearest alternatives
Catalog snapshot. Check linked sources for current price, label and batch-specific testing.
Price verification
Current price: $65.00
Last price check: Sep 01, 2026
Layer 2 · Context

Our summary

Timeline Mitopure Softgels deliver 500 mg/day of a proprietary, highly purified synthetic urolithin A, the same branded ingredient and dose used in two of the field's flagship human RCTs (Andreux 2019 in Nature Metabolism; Singh 2022's ATLAS trial in Cell Reports Medicine), both of which found favorable safety and measurable, if secondary-endpoint, gains in mitochondrial biomarkers and muscle strength. This is a rare case in the longevity-supplement category where the sold product, dose, and clinical evidence line up almost exactly, but nearly every trial was funded by and co-authored with the manufacturer, Amazentis SA, and no fully independent replication of the strength/endurance findings exists yet. At roughly $3.75-$4.17 per daily dose (subscription vs. one-time), it is priced at a significant premium versus most single-ingredient longevity products, and independent reviewers (ConsumerLab, Trustpilot) are noticeably more cautious about real-world benefit than the vendor's own 4.5-4.7 star review page. Buyers should understand they are paying for the best-documented delivery mechanism for urolithin A available, not for outcomes proven independent of the company that makes it.
In plain language

Why this scored this way

This Timeline Nutrition Mitopure® Softgel scores 8.6, making it one of the highest-scoring products on the site. It delivers 500mg of Urolithin A, inside the studied range of 500–1000mg with grade A evidence (strong human trial data). At $4.33/day it's among the more expensive options in Mitochondrial.

What drives the score up

  • Dose-evidence score of 10.0 reflects good alignment with trial doses.
  • Tested by independent lab (transparency 8.0).
  • Community score of 8.6 with positive consumer feedback.
  • Urolithin A is dosed at the full research level with grade A evidence (strong human trial data).

What drags it down

  • No public lab certificate available for independent verification.
  • At $4.33/day it's on the expensive side.

Why you'd choose it

  • You want Urolithin A from a Timeline Nutrition product.
  • You want a tested by independent lab product.
  • You want doses that align with published research.

Why you might skip it

  • You want a product with a publicly available CoA.
  • You want a cheaper option (this is $4.33/day).
Question 1

Does the molecule work?

The science behind each active ingredient, independent of which brand sells it.

Urolithin A

A mitophagy-activating metabolite with early human data; both flagship RCTs missed their primary endpoints.

2 landmark RCTs · US: FDA GRAS · EU: Authorised Novel Food (EU 2021/85)
Question 2

Is this bottle good?

The specific product: dose, price, transparency, and what buyers report.

Dose vs research
100% of trial dose
Meets or exceeds the published effective dose
Cost at trial dose
$4.33/day at trial dose
What one effective daily dose actually costs
Transparency
8.0/10 · No public lab certificate
Independent batch testing confirmed
Consumer signals
No consumer signals collected yet
Operational signal only, never used as clinical evidence
Question 3

What's the catch?

Safety flags, transparency gaps, dosing concerns, and recurring buyer complaints.

No public lab certificate
Certificate of Analysis not published
Without a public lab certificate, batch purity and potency cannot be independently verified.
Plain English

What’s inside

The main ingredients of this product, in plain language.

Urolithin A500 mgEvidence A

A mitophagy-activating metabolite with early human data; both flagship RCTs missed their primary endpoints.

Read about Urolithin A →
Layer 3 · Evidence vault

Product data & verification

Hard numbers and independently checked status. Expand each block for its source.

The numbers

Price
$65
per bottle · 30 servings
Dose vs. research
of trial dose 100%
of published effective dose
$ / day at studied dose
$4.33
what one effective daily dose costs
$ / g active
$4.33
per gram of active substance
Independently checked

Data verification

COA status
Not public
Evidence grade
A
Per-ingredient breakdown
AUrolithin A

All product data is checked against original sources. Prices, doses, and testing status are updated when product pages change. Evidence grades are reviewed when new human RCTs are published. Read how we verify.

What's inside

Ingredient
Dose in this product
Trial dose
Evidence
Urolithin A
A mitophagy-activating metabolite with early human data; both flagship RCTs missed their primary endpoints.
500 mg 50% of trial dose
1000 mg
4.3 /5
High confidence Strong value signal
5,606 reviews across 5 platforms (5 sources)
Source diversity: 100%
Cell Reports Medicine (Singh 2022)Nature Metabolism (Andreux 2019)Timeline (brand site)Timeline (brand site, product page)Trustpilot
PraisePeer-reviewed Nature study showed Mitopure® induces mitophagy in humans at 500 aReplication RCT: 4 months of 500/1000 mg improved muscle endurance in older adul
Last checked: 2026-08-20

Consumer signals

Consumer signals gathered from 5 platforms.

Medium confidence

Consumer sentiment compiled from 3 public sources (Cell Reports Medicine (Singh 2022), Nature Metabolism (Andreux 2019), Trustpilot).

positive sentiment

Praise

Peer-reviewed Nature study showed Mitopure® induces mitophagy in humans at 500 and 1000 mg.

Compiled from a Nature Metabolism (Andreux 2019) listing located during manual research; not independently re-verified against the live page at build time.

positive sentiment

Praise

Replication RCT: 4 months of 500/1000 mg improved muscle endurance in older adults.

Compiled from a Cell Reports Medicine (Singh 2022) listing located during manual research; not independently re-verified against the live page at build time.

7 reviews · 4.2/5 · mixed sentiment

Themes4.2/5. Positive for effect; users note the price point.

Compiled from a Trustpilot listing located during manual research; not independently re-verified against the live page at build time.

4,485 reviews · 4.5/5

These are consumer sentiment signals. They do not measure whether the product actually works. See our evidence section for that.

Independent external anchors

Public sources on this same product, unrelated to NO1GEVITY. NIH DSLD is the US government's registered label database (shown verbatim). SuppCo.com is a separate, unaffiliated commercial site with no partnership or data-sharing arrangement with us. NO1GEVITY scores are computed independently of both.

Unaffiliated third-party site
SuppCo.com

SuppCo is a separate, unaffiliated supplement-tracking site with no partnership, data-sharing agreement, or business relationship with NO1GEVITY. We are not endorsed by them and they do not endorse us. The two facts below are individually verified against the manufacturer or NSF; the outbound link is provided only so readers can independently cross-check on a third-party site if they want to.

Tested by independent lab, Yes

What others say, with a source hierarchy

We treat external opinion very differently depending on where it comes from. Tier A is our strongest signal. Tier C is background sentiment only. Tier Rejected is what we excluded, listed openly so you can see what we discarded.

These reviews are aggregated from third-party sources, not written by NO1GEVITY. Each entry shows its source, retrieval date, and whether the source has an affiliate or paid relationship. We do not edit reviews to change their meaning. Disclosure policy.

Tier A

Independent deep reviews, lab tests, certificates of analysis

Our strongest external evidence. Long-form independent reviews, physical-product lab work, and third-party certifications.

Innerbody
Has affiliate relationship Not a paid placement

Innerbody concludes Mitopure is a 'research-supported' urolithin A product with a genuinely favorable safety record (citing a 2024 systematic review finding no serious adverse events across studies) and plausible benefits for mitochondrial/muscle health, but flags the price as high relative to competing products.

Finding: 4.46-star average across ~5,000 on-site (Junip) reviews with 97% recommend rate; independently tabulated pricing showing $125/month one-time down to $85/month on 12-month subscription ($2.83-$4.17 per serving)
How we use it: Used as primary independent source for pricing structure and safety-literature synthesis; Innerbody discloses its review methodology and is not a blind affiliate roundup, though it does carry affiliate links, so quantitative brand-satisfaction figures (4.46 stars) are treated as vendor-adjacent rather than fully independent.
ConsumerLab.com
No affiliate relationship Not a paid placement

ConsumerLab's free summary takes a notably more cautious tone than Timeline's own marketing, characterizing the muscle-health evidence base as showing only 'limited benefit,' and separately notes that some marketed urolithin A brands have been subject to a federal manufacturing/sales ban for quality violations.

Finding: Full comparative product testing and cost analysis (including Timeline Mitopure) is paywalled behind ConsumerLab membership; the public summary states clinical research 'has suggested only limited benefit in improving muscle health' in active young, middle-aged, or older adults
How we use it: Cited as an independent, non-affiliate, subscription-funded evaluator whose free-tier framing is more conservative than the vendor's; full product-specific dosage/purity comparison data was not accessible without a paid membership, so we rely on the publicly visible summary only.
lifespan.io (Rejuvenation Roadmap)
No affiliate relationship Not a paid placement

lifespan.io frames urolithin A as a legitimate, mechanistically interesting mitochondrial-health compound with 'positive results' in early human trials, describing it as part of the broader academic longevity research landscape rather than reviewing Timeline as a commercial product per se.

Finding: No numeric product rating; narrative summary of Amazentis's research history and 2020 Timeline product launch
How we use it: Used for brand/company history context (non-commercial, non-affiliate longevity research nonprofit perspective) rather than as a product-purchase recommendation source.
Tier B

Registered dietitians and physicians, without affiliate ties

Credentialed commentary from clinicians who disclose no paid relationship. Useful as supporting critique but not a substitute for a clinical outcome trial.

Trustpilot (timeline.com)
No affiliate relationship Not a paid placement

Independent Trustpilot reviewers report a substantially less favorable experience than the vendor's own review page, with recurring complaints about lack of noticeable results after 3+ months and hundreds of dollars spent, and difficulty with subscription cancellation/refunds.

Finding: US Trustpilot listing shows a markedly lower 2.5/5 rating (small sample, ~7 reviews) with complaints of poor efficacy, high price, and refund difficulty
How we use it: Weighted as an important independent counterbalance to the vendor's 4.5-4.7 star self-hosted figures; sample size is small (single digits to low dozens per region) so treated as directionally informative rather than statistically definitive. A separate Canadian Trustpilot listing (timelinenutrition.com) shows a similar 'Average' 3.2/5 rating with value-for-money complaints, particularly about skincare pricing.
Tier C

Aggregated sentiment (Trustpilot, Reddit)

Mood indicator only. We never use aggregate stars as evidence of efficacy.

Timeline (vendor-hosted reviews page)
No affiliate relationship Not a paid placement

Overwhelmingly positive self-hosted review aggregate, though several visible negative reviews cite lack of noticeable effect, high price, and customer-service/shipping issues.

Finding: 4.7/5 average based on 13,259 reviews (Softgels specifically: 4.5/5 based on 4,330-4,465 reviews)
How we use it: Used only as context for the vendor's self-reported customer sentiment; not treated as independent evidence given it is a first-party-hosted review widget (Junip) subject to selection and moderation by the seller.

Community threads and aggregate ratings

Additional public mentions we located, kept separate from the deep independent reviews above.

Nature Metabolism (Andreux 2019)
positive

Peer-reviewed Nature study showed Mitopure® induces mitophagy in humans at 500 and 1000 mg.

Read source → Unverified · we received no payment for this listing
Cell Reports Medicine (Singh 2022)
positive

Replication RCT: 4 months of 500/1000 mg improved muscle endurance in older adults.

Read source → Unverified · we received no payment for this listing
Trustpilot · 4.2
mixed

4.2/5. Positive for effect; users note the price point.

Read source → Unverified · we received no payment for this listing
Layer 3 · Evidence vault

Evidence, claims & regulation

Published evidence, claim checks, regulatory status and what could not be verified.

Evidence, what actually backs this product

Longevity brands rarely test their exact finished product. We separate what's tested from what's inferred.

Strongest evidence tier
Tier 1Product RCT (peer-reviewed)
5 studies mapped
Tier 1Product RCT (peer-reviewed)
The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans
Andreux PA, Blanco-Bose W, Ryu D, Burdet F, Ibberson M, Aebischer P, Auwerx J, Singh A, Rinsch C · 2019 · Nature Metabolism · n=60 · Single ascending doses (250-2,000 mg) and 28-day repeated dosing at 250, 500, or 1,000 mg/day of Mitopure urolithin A softgels · Single dose and 28 days (4 weeks)
on this exact productpeer-reviewed
Favorable safety profile and dose-dependent plasma bioavailability; 500 mg and 1,000 mg doses modulated plasma acylcarnitines and upregulated mitochondrial gene expression in skeletal muscle biopsies, the first direct human evidence of a molecular mitophagy/mitochondrial signature from oral UA.
First-in-human trial; safety/biomarker endpoints only, no functional (strength/endurance) outcome measured. Uses the exact Mitopure softgel formulation and the exact 500 mg dose sold in this product. Directly on-ingredient, on-dose, on-product-family.
Conflicts: Funded and co-authored by Amazentis SA (maker of Mitopure/Timeline); several authors are Amazentis employees or founders (Rinsch, Singh). Independent EPFL/SIB co-authors (Auwerx lab) also contributed.
Tier 1Product RCT (peer-reviewed)
Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults
Singh A, D'Amico D, Andreux PA, Fouassier AM, Blanco-Bose W, Evans M, Aebischer P, Auwerx J, Rinsch C · 2022 · Cell Reports Medicine · n=88 · 500 mg/day (n=29) or 1,000 mg/day (n=30) Mitopure urolithin A vs placebo (n=29) · 4 months (120 days)
on this exact productpeer-reviewed
Both UA doses significantly increased hamstring leg-muscle strength (+12% at 500 mg, p=0.027; +9.8% at 1,000 mg, p=0.029, vs placebo) and knee-flexion strength (+10.6% and +10.5% respectively); the pre-specified primary endpoint (peak power output) was not significantly improved. Plasma acylcarnitines and C-reactive protein fell, and skeletal-muscle biopsies showed increased mitophagy/OXPHOS protein expression.
Exact Mitopure formulation and exact 500 mg dose sold in this product, at a matching population (overweight middle-aged adults). Primary efficacy endpoint (power output) was not met, only secondary strength/biomarker endpoints reached significance, so results should be read as promising-but-mixed rather than an unambiguous efficacy win.
Conflicts: Funded by Amazentis SA; several authors (D'Amico, Fouassier, Blanco-Bose, Evans, Rinsch, Singh) are Amazentis/Timeline employees. Trial registered as sponsor Amazentis SA.
Tier 2Product RCT (not peer-reviewed)
Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial
Liu S, D'Amico D, Shankland E, Bhayana S, Garcia JM, Aebischer P, Rinsch C, Singh A, Marcinek DJ · 2022 · JAMA Network Open · n=66 · 1,000 mg/day Mitopure urolithin A (n=33) vs placebo (n=33) · 4 months
ingredient-levelpeer-reviewed
UA significantly improved muscle endurance (number of contractions to fatigue) in both hand (FDI) and leg (tibialis anterior) muscles at 2 months, with favorable plasma biomarker changes (lower acylcarnitines, ceramides, CRP) at 4 months. The trial's two co-primary endpoints, 6-minute walk distance and maximal ATP production in hand muscle, did NOT reach statistical significance versus placebo.
Uses Mitopure but at 1,000 mg/day, double the 500 mg/day dose sold in this specific softgel product (which is 2 softgels = 500 mg). Because the labeled and vendor-recommended dose of this SKU is 500 mg/day, this trial is evidence for a higher dose than what a standard user of this exact product takes; it supports the ingredient/brand but not this product's exact serving size. Also notable: both co-primary endpoints were null; only secondary endurance/biomarker outcomes were positive.
Conflicts: Funded by Amazentis SA; co-authors D'Amico, Rinsch, and Singh are Amazentis employees. Academic PI (Marcinek, University of Washington) and clinical site were independent of the sponsor.
Tier 5Mechanistic / animal / marketing
Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variation
D'Amico D, Andreux PA, Valdés P, Singh A, Rinsch C, et al. · 2021 · Aging Cell / related Amazentis-funded PK study (published in peer-reviewed literature, PMC8821002) · Comparison of pomegranate juice-derived UA exposure vs. direct Mitopure UA supplementation · Acute/short-term PK comparison
ingredient-levelpeer-reviewed
Only ~12% of subjects had detectable urolithin A at baseline; only ~40% became measurable 'producers' after a pomegranate-juice ellagitannin challenge. Direct UA supplementation (Mitopure) provided over 6-fold higher plasma UA exposure than pomegranate juice, bypassing gut-microbiome-dependent conversion entirely.
Key mechanistic support for the core Timeline value proposition, this is not an efficacy trial but establishes why direct UA dosing is pharmacokinetically superior to relying on dietary ellagitannin conversion for the ~60-70% of people who are poor/non-producers.
Conflicts: Amazentis-affiliated authors (D'Amico, Andreux, Valdés, Singh, Rinsch); Amazentis-funded study.
Tier 5Mechanistic / animal / marketing
Ellagic Acid Metabolism by Human Gut Microbiota: Consistent Observation of Three Urolithin Phenotypes in Intervention Trials, Independent of Food Source, Age, and Health Status
Tomás-Barberán FA, García-Villalba R, González-Sarrías A, Selma MV, Espín JC · 2014 · Journal of Agricultural and Food Chemistry · Dietary ellagitannin/ellagic acid sources (pomegranate, walnuts, berries), not a UA supplement study · Not applicable (pooled cross-study review)
ingredient-levelpeer-reviewed
Establishes three consistent human 'urolithin metabotypes': Phenotype A (produces only urolithin A conjugates, 25-80% of volunteers across trials), Phenotype B (produces isourolithin A/urolithin B in addition, 10-50%), and Phenotype 0 (non-producers, 5-25%), independent of age, health status, or ellagitannin food source.
Foundational, independent (non-Amazentis) academic evidence for the 'only ~30-40% of people are efficient UA producers from diet' claim that underlies Timeline's core marketing pitch, that direct UA supplementation bypasses an unreliable biological lottery.
Conflicts: None identified; independent Spanish academic research group (CEBAS-CSIC), not funded by Amazentis.
Evidence

Research behind this product

The studies that established the trial dose and evidence grade for each active ingredient in this product. Click through to read the original paper.

Claim check, vendor claims vs. our reading of the evidence

Not medical advice. We list the strongest claims made by the brand and check each against traceable evidence.

Supported
“Mitopure is the only clinically studied and FDA GRAS-designated form of Urolithin A”
Mitopure is confirmed as the subject of FDA GRAS Notice GRN 000791 (https://www.fda.gov/media/120300/download) and is the formulation used in essentially every published human RCT on urolithin A identified in this review, including Andreux 2019, Singh 2022, and Liu 2022. No competing branded UA ingredient with comparable clinical trial volume was identified.
Partial support
“Mitochondrial renewal increases by +39% after 16 weeks over placebo (gold-standard clinical trial graphic)”
The underlying ATLAS trial (Singh et al. 2022, Cell Reports Medicine) reported significant increases in mitophagy/mitochondrial protein and gene expression markers in skeletal-muscle biopsies, and dose-dependent OXPHOS protein increases, but the specific '+39%' single figure could not be independently located in the peer-reviewed paper's abstract or results text in this pass, it appears to summarize a specific biomarker sub-analysis rather than a headline trial result, and the primary endpoint (peak power output) was NOT significantly improved in that same trial.
Supported
“Improves cellular health / boosts cellular energy and muscle health by renewing mitochondria”
Mechanistically well-supported: multiple Amazentis-funded human RCTs (Andreux 2019, Singh 2022) show increased mitophagy/mitochondrial gene and protein expression in skeletal muscle biopsies at the 500 mg dose, consistent with animal/cell mechanistic literature on urolithin A and PINK1/Parkin-mediated mitophagy.
Partial support
“You're getting stronger, even without a change in your exercise routine (implied 4-month strength benefit)”
Supported by the Singh 2022 ATLAS trial's secondary strength endpoints (+12% hamstring strength at 500 mg vs placebo, p=0.027), but that trial's pre-specified PRIMARY endpoint (peak power output) was not significantly different from placebo, and effect sizes are modest with wide confidence intervals in a single 88-person trial. The claim omits that this is a secondary-endpoint finding, not the trial's main confirmed result.
Unverifiable
“Doctor Recommended #1 (per companion Gummies/Powder product badges) / 4.7/5 based on 12,000+ reviews”
Timeline's own review counts and star ratings are self-hosted (via Junip review platform) rather than from an independent third party; 'Doctor Recommended' badges are not sourced to any named survey methodology on the page. Independent Trustpilot ratings for timeline.com are considerably lower and more mixed (see external_reviews_registry), suggesting the on-site review sample may not be representative of the full buyer population.

Regulatory status

Rules change often. We record when we last verified each row. See the full regulatory timeline →

What we could not verify

We list this openly. If a claim isn't backed by a source we can trace, we'd rather flag it than repeat it.

  • No public, batch-specific Certificate of Analysis (COA) for the Mitopure Softgels SKU was located, despite NSF Certified for Sport and Clean Label Project badges being advertised on the vendor page.
  • Manufacturing location/facility for the softgel product itself was not disclosed in the pages reviewed.
  • The specific '+39% mitochondrial renewal over placebo at 16 weeks' figure cited in vendor marketing could not be traced to an exact number in the peer-reviewed Singh et al. 2022 paper in this pass, it may derive from a specific sub-analysis, investor deck, or press summary not fully replicated in the published manuscript.
  • Long-term (>4-6 months) safety and efficacy data in humans beyond the trials reviewed here is limited; the longest completed RCT identified was 4 months.
  • Independent (non-Amazentis-funded, non-Amazentis-authored) replication of the muscle strength/endurance findings is limited, nearly all human RCT evidence to date on Mitopure was funded by, or co-authored by employees of, Amazentis SA, the product's own manufacturer.
  • Current live pricing on timeline.com could not be re-confirmed via direct page fetch at time of this review (fetch timed out); price figures rely on Innerbody's and a third-party retailer's (Workup) independently published tables, both dated within the past several months and mutually consistent.
  • Trustpilot aggregator

    This is a brand-level customer-service profile for timeline; it does not isolate Mitopure® Softgel.

    verified 2026-08-07Open source →
  • Reddit r/Supplements community forum
    mixed sentiment

    Community discussion exists around Mitopure Softgel, with some users reporting improved muscular endurance while others questioning whether it works. No single Reddit thread is treated as a representative product review.

    no direct URLchecked 2026-08-07
  • Timeline on-site reviews own platform
    4.5/54472 reviews

    Timeline displays first-party softgel reviews on its public page.

    verified 2026-08-07Open source →
Important to know
Urolithin ACheap 'urolithin A precursor' products (pomegranate extract) don't work if you lack the right gut bacteria. Only direct Urolithin A supplements are reliable.

Editorial notes

Patented Mitopure® ingredient. Two softgels/day = 500 mg. Full 1000 mg trial dose costs ~$130/mo.

Brand owners

Spot an error?

If you are the manufacturer or brand owner of Mitopure® Softgel and believe any data on this page is incorrect (wrong dose, wrong ingredient, wrong price, missing certification, outdated status), you can request a correction.

We review every request, verify it against primary sources, and publish any accepted change with a dated note. Corrections from brand owners are treated the same as corrections from anyone else: verified before they move.

Request a correction →
Same shelf

Similar products

All Mitochondrial →

The next highest-scoring products in Mitochondrial, same scoring method, same rules.

Mitochondrial
Active per serving
Urolithin A 500 mgCapsule · 30 servings
Price per serving
$1.87$55.97 · 30 servings
Testing
3rd-party listed · public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 8.6/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$3.73
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with www.prohealth.com
Mitochondrial
Active per serving
Creatine 10 gPowder · 30 servings
Price per serving
$0.88$26.50 · 30 servings
Testing
3rd-party listed · no public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 8.6/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$0.44
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with donotage.org
Double Wood Supplements
Mitochondrial
Active per serving
Alpha-Lipoic Acid 600 mgCapsule · 30 servings
Price per serving
$0.66$19.95 · 30 servings
Testing
3rd-party listed · public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 8.5/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$0.66
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with doublewoodsupplements.com
Same maker

Other products from Timeline Nutrition

Brand profile →
Timeline Nutrition
Mitochondrial
Active per serving
Urolithin A 1,000 mgPowder stick · 28 servings
Price per serving
$4.64$130.00 · 28 servings
Testing
3rd-party listed · no public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 8.2/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$4.64
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with www.timeline.com
Mitochondrial
Active per serving
Urolithin A 500 mgGummy · 30 servings
Price per serving
$4.17$125.00 · 30 servings
Testing
3rd-party listed · no public lab certificate

Status as recorded in the catalog from brand materials; not independently verified by NO1GEVITY.

Score & research context 8.1/10

Editorial score, not proof that this product works. Research-dose calculations are not dosing advice.

100%
of trial dose
$8.33
per research-dose day, not label serving
0Trial dose2×
Catalog price · Confirm current price with www.timeline.com